Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
MJMichael J. TopperMVMichelle VazKBKatherine B. ChiappinelliCEChristina E. DeStefano ShieldsNNNoushin Niknafs
Johns Hopkins University · Johns Hopkins Medicine · +4 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
518
total citations
- FWCI
- 17.38
- Percentile
- 100%
- References
- 59
Citations per year
Authors
18- MJMichael J. Topper
Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center
- MVMichelle Vaz
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
- KBKatherine B. Chiappinelli
George Washington University
- CEChristina E. DeStefano Shields
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
- NNNoushin Niknafs
Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Topics & keywords
Topics
Keywords
- Biology
- Cancer research
- Lung cancer
- Immune system
- Vorinostat
- Histone deacetylase
- Epigenetic therapy
- Immunotherapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.